Mesenchymal stem cells that produce neurotrophic factors reduce ischemic damage in the rat middle cerebral artery occlusion model
Top Cited Papers
Open Access
- 1 January 2005
- journal article
- research article
- Published by Elsevier in Molecular Therapy
- Vol. 11 (1) , 96-104
- https://doi.org/10.1016/j.ymthe.2004.09.020
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education and Science (14370433, 14571312)
This publication has 53 references indexed in Scilit:
- BDNF Gene-Modified Mesenchymal Stem Cells Promote Functional Recovery and Reduce Infarct Size in the Rat Middle Cerebral Artery Occlusion ModelMolecular Therapy, 2004
- Imaging-Based Decision Making in Thrombolytic Therapy for Ischemic StrokeStroke, 2003
- Effective Gene Transfer to Human Melanomas via Integrin-Targeted Adenoviral VectorsHuman Gene Therapy, 2002
- Neurotrophin-3 Promotes Cell Death Induced in Cerebral Ischemia, Oxygen-Glucose Deprivation, and Oxidative Stress: Possible Involvement of Oxygen Free RadicalsNeurobiology of Disease, 2002
- A tropism-modified adenoviral vector increased the effectiveness of gene therapy for arthritisGene Therapy, 2001
- Adenovirus-Mediated GDNF and CNTF Pretreatment Protects against Striatal Injury Following Transient Middle Cerebral Artery Occlusion in MiceNeurobiology of Disease, 2001
- T2‐Weighted MRI Correlates with Long‐Term Histopathology, Neurology Scores, and Skilled Motor Behavior in a Rat Stroke ModelAnnals of the New York Academy of Sciences, 2001
- Intravenous Brain-Derived Neurotrophic Factor Reduces Infarct Size and Counterregulates Bax and Bcl-2 Expression After Temporary Focal Cerebral IschemiaStroke, 2000
- The trk Proto-Oncogene Product: a Signal Transducing Receptor for Nerve Growth FactorScience, 1991
- Type-2 astrocyte development in rat brain cultures is initiated by a CNTF like protein produced by type-1 astrocytesNeuron, 1988